Postoperative adjuvant therapy for 120 patients with melanoma, including acral and mucosal subtypes: a multicentre, observational study of 2-year follow-up results

Abstract

We retrospectively analysed 120 cases of melanoma in Japanese patients in the adjuvant setting as an observational study. Nonacral cutaneous-type melanoma (low-CSD and high-CSD types) had significantly better RFS than acral-type melanoma. On multivariate analyses, the acral subtype and agents used in adjuvant therapy were identified as important prognostic factors.